14,138
Views
128
CrossRef citations to date
0
Altmetric
Reviews

Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases

, , , &
Pages 3-19 | Received 14 Jun 2016, Accepted 22 Dec 2016, Published online: 19 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Fan Shi, Ran Xue, Xuexiao Zhou, Pei Shen, Shengzhi Wang & Yun Yang. (2021) Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease. Immunopharmacology and Immunotoxicology 43:6, pages 666-673.
Read now
Ahmed M. Abu El-Asrar, Nele Berghmans, Saleh A. Al-Obeidan, Priscilla W. Gikandi, Ghislain Opdenakker, Jo Van Damme & Sofie Struyf. (2020) Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities. Ocular Immunology and Inflammation 28:3, pages 453-462.
Read now
Mary Helen Foster & Jeffrey Robinson Ord. (2019) Emerging immunotherapies for autoimmune kidney disease. Human Vaccines & Immunotherapeutics 15:4, pages 876-890.
Read now
Mauro Alaibac. (2019) Biological therapy of autoimmune blistering diseases. Expert Opinion on Biological Therapy 19:2, pages 149-156.
Read now
Rosanna Dammacco, Pasquale Procaccio, Vito Racanelli, Angelo Vacca & Franco Dammacco. (2018) Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers. Ocular Immunology and Inflammation 26:8, pages 1154-1165.
Read now
Eric Sanchez, Edward J. Tanenbaum, Saurabh Patil, Mingjie Li, Camilia M. Soof, Aleksandra Vidisheva, Gabriel N. Waterman, Tara Hekmati, George Tang, Cathy S. Wang, Haiming Chen & James Berenson. (2018) The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker. Expert Review of Molecular Diagnostics 18:4, pages 319-329.
Read now
Himanshu Kumar & Adrian Bot. (2017) In this issue: Antibodies in pathogenesis and management of diseases. International Reviews of Immunology 36:1, pages 1-2.
Read now

Articles from other publishers (121)

Yongze Zhuang, Hailing Lu & Junxia Li. (2023) Advances in the treatment of IgA nephropathy with biological agents. Chronic Diseases and Translational Medicine.
Crossref
Liqi Huang, Wenjian Lin, Yu Liu, Junfeng Zhu, Yun Li, Zhihua Zheng & Chun Tang. (2023) Combination treatment with telitacicept, cyclophosphamide and glucocorticoids for severe Granulomatous polyangiitis: a case report and literature review. Frontiers in Immunology 14.
Crossref
Chloe E C Williams, Megan Lamond, Julien Marro, Andrew J Chetwynd & Louise Oni. (2023) A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP). Clinical Rheumatology 42:12, pages 3189-3200.
Crossref
Mohit Mathur, Tak Mao Chan, Kook-Hwan Oh, Laura Kooienga, Min Zhuo, Cibele S. Pinto & Bobby Chacko. (2023) A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence. Journal of Clinical Medicine 12:21, pages 6927.
Crossref
Zhuo Zhang, Xin Xie, Ying Cai, Peipei Liu, Shoufeng Liu, Rongjie Chen, Jin Wang, Yue Wang, Yanan Zhao, Zhizhong Zhu, Xinyuan Zhang & Jialing Wu. (2023) Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease. Parkinsonism & Related Disorders 116, pages 105890.
Crossref
Yuemiao Zhang, Yi-Tong Hu, Ji-Cheng Lv & Hong Zhang. (2023) Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial. Pediatric Nephrology 38:10, pages 3211-3220.
Crossref
Lijun Wu, Xinru Du & Xuehong Lu. (2023) Role of telitacicept in the treatment of IgA nephropathy. European Journal of Medical Research 28:1.
Crossref
Xiuzhi Jia, Li Tan, Sixiu Chen, Ruihan Tang & Wei Chen. (2023) Monogenic lupus: Tracing the therapeutic implications from single gene mutations. Clinical Immunology 254, pages 109699.
Crossref
Jingyue Li, Mingjiu Zhao, Wenjun Luo, Jiaqi Huang, Bin Zhao & Zhiguang Zhou. (2023) B cell metabolism in autoimmune diseases: signaling pathways and interventions. Frontiers in Immunology 14.
Crossref
Miriam L. Fichtner, Heike Rübsamen, Michaela Smolle, Jonas Schaller, Regina Feederle, Andreas Bültmann, Tania Kümpfel, Pascal Schneider, Franziska S. Thaler & Edgar Meinl. (2023) Features of Isoforms of Human Soluble TACI. The Journal of Immunology 211:2, pages 199-208.
Crossref
Dong Xu, Jianmin Fang, Shangzhu Zhang, Cibo Huang, Chenghui Huang, Li Qin, Xiaomei Li, Meiqing Chen, Xiumei Liu, Yi Liu, Zhijun Li, Jiankang Hu, Chunde Bao, Wei Wei, Jing Tian, Xinwang Duan & Xiaofeng Zeng. (2023) Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial. Rheumatology.
Crossref
Panagiotis Athanassiou & Lambros Athanassiou. (2023) Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus. Life 13:7, pages 1496.
Crossref
Lawrence S. Evans, Katherine E. Lewis, Daniel DeMonte, Janhavi G. Bhandari, Logan B. Garrett, Joseph L. Kuijper, Daniel Ardourel, Martin F. Wolfson, Susan Debrot, Sherri Mudri, Kayla Kleist, Luana L. Griffin, LuAnne Hebb, Russell J. Sanderson, NingXin Wang, Michelle Seaberg, Allison G. Chunyk, Jing Yang, Youji Hong, Zahra Maria, David J. Messenheimer, Pamela M. Holland, Stanford L. Peng, Mark W. Rixon & Stacey R. Dillon. (2023) Povetacicept, an Enhanced Dual APRIL / BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases . Arthritis & Rheumatology 75:7, pages 1187-1202.
Crossref
Micaela Gentile, Luis Sanchez-Russo, Leonardo V Riella, Alberto Verlato, Joaquin Manrique, Simona Granata, Enrico Fiaccadori, Francesco Pesce, Gianluigi Zaza & Paolo Cravedi. (2023) Immune abnormalities in IgA nephropathy. Clinical Kidney Journal 16:7, pages 1059-1070.
Crossref
Dimitra Petrou, Petros Kalogeropoulos, George Liapis & Sophia Lionaki. (2023) IgA Nephropathy: Current Treatment and New Insights. Antibodies 12:2, pages 40.
Crossref
Vincenzo Di Leo, Francesca Annese, Federica Papadia, Iris Cara, Marica Giliberti, Fabio Sallustio & Loreto Gesualdo. (2023) The Landscape of IgA Nephropathy Treatment Strategy: A Pharmacological Overview. Future Pharmacology 3:2, pages 517-534.
Crossref
Ruihe Liu, Tian Liu, Jing He, Hua Ye, Yuzhou Gan & Chun Li. (2023) Efficacy of telitacicept in patients with lupus‐ and antiphospholipid syndrome‐associated refractory thrombocytopenia. Rheumatology & Autoimmunity.
Crossref
Carolina Conte, Giulia Antonelli, Maria Elena Melica, Mirko Tarocchi, Paola Romagnani & Anna Julie Peired. (2023) Role of Sex Hormones in Prevalent Kidney Diseases. International Journal of Molecular Sciences 24:9, pages 8244.
Crossref
Ajinath Kale, Maciej Lech, Hans-Joachim Anders & Anil Bhanudas Gaikwad. (2023) Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. BioDrugs.
Crossref
Maria Antonella Zingaropoli, Patrizia Pasculli, Matteo Tartaglia, Federica Dominelli, Federica Ciccone, Ambra Taglietti, Valentina Perri, Leonardo Malimpensa, Gina Ferrazzano, Marco Iannetta, Cosmo Del Borgo, Miriam Lichtner, Claudio Maria Mastroianni, Antonella Conte & Maria Rosa Ciardi. (2023) Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk. Biology 12:4, pages 587.
Crossref
Le Deng & Gaosi Xu. (2023) Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy. Drugs 83:6, pages 507-530.
Crossref
Md Ashik Ullah & Fabienne Mackay. (2023) The BAFF-APRIL System in Cancer. Cancers 15:6, pages 1791.
Crossref
Daniela Giordano, Runa Kuley, Kevin E. Draves, Keith B. Elkon, Natalia V. Giltiay & Edward A. Clark. (2023) B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease. Frontiers in Immunology 14.
Crossref
Diane Giovannini, Aude Belbezier, Athan Baillet, Laurence Bouillet, Mitsuhiro Kawano, Chantal Dumestre-Perard, Giovanna Clavarino, Johan Noble, Jacques-Olivier Pers, Nathalie Sturm & Bertrand Huard. (2023) Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues. Frontiers in Immunology 14.
Crossref
Ziyang Wang, Yueying Wang, Yuke Cui, Zhiyong Chen, Lei Yi, Zhengbin Zhu, Jingwei Ni, Run Du, Xiaoqun Wang, Jinzhou Zhu, Fenghua Ding, Weiwei Quan, Ruiyan Zhang, Jian Hu & Xiaoxiang Yan. (2023) Association of Serum BAFF Levels with Cardiovascular Events in ST-Segment Elevation Myocardial Infarction. Journal of Clinical Medicine 12:4, pages 1692.
Crossref
Marcello Pinti, Lara Gibellini, Domenico Lo Tartaro, Sara De Biasi, Milena Nasi, Rebecca Borella, Lucia Fidanza, Anita Neroni, Leonarda Troiano, Claudio Franceschi & Andrea Cossarizza. (2023) A Comprehensive Analysis of Cytokine Network in Centenarians. International Journal of Molecular Sciences 24:3, pages 2719.
Crossref
Hong-Chang Xie, Zhi-Gang Wang, Yong-Hua Feng, Jun-Xiang Wang, Lei Liu, Xian-Lei Yang, Jin-Feng Li & Gui-Wen Feng. (2023) Bone marrow mesenchymal stem cells repress renal transplant immune rejection by facilitating the APRIL phosphorylation to induce regulation B cell production. Physiological Genomics 55:2, pages 90-100.
Crossref
Shangyao Qin, Yimin Yuan, Hong Liu, Yingyan Pu, Kefu Chen, Yulong Wu & Zhida Su. (2022) Identification and characterization of sex‐dependent gene expression profile in glioblastoma. Neuropathology 43:1, pages 72-83.
Crossref
Han Wang, Dan Mei, Fa-qin Liang, Zi-yang Xue, Pan Wang, Rui-jin Liu, Yu-chen Zhao, Lin Jin, Zi-wei Zhang, Yuan-fang Zhai, Xian-zheng Zhang, Wei Wei & Ling-ling Zhang. (2023) BAFF Promotes FLS Activation Through BAFFR-Mediated Non-canonical NF-κB Pathway and the Effects of CP-25. Inflammation.
Crossref
正子 李. (2023) Research Progress in the Treatment of IgA Nephropathy. Advances in Clinical Medicine 13:07, pages 11080-11087.
Crossref
寒 孔. (2023) Application of Belizumab in Lupus Nephritis. Advances in Clinical Medicine 13:05, pages 8421-8430.
Crossref
华明 鲜. (2023) New Progress in the Treatment of IgA Nephropathy. Advances in Clinical Medicine 13:02, pages 2272-2285.
Crossref
Romain Marignier, Olivier Casez & Bertrand Huard. 2023. Translational Neuroimmunology, Volume 7. Translational Neuroimmunology, Volume 7 425 434 .
Mahya Eslami, Daniela Willen, Orestis Papasouliotis, Sonia Schuepbach-Mallpell, Laure Willen, Olivier Donzé, Özkan Yalkinoglu & Pascal Schneider. (2022) Kinetics of free and ligand-bound atacicept in human serum. Frontiers in Immunology 13.
Crossref
Pilar Ortiz-Aljaro, Marco Antonio Montes-Cano, José-Raúl García-Lozano, Virginia Aquino, Rosario Carmona, Javier Perez-Florido, Francisco José García-Hernández, Joaquín Dopazo & María Francisca González-Escribano. (2022) Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus. Scientific Reports 12:1.
Crossref
Zhan Shen, Jiao Ma, Rongmei Peng, Bohao Hu, Yinghan Zhao, Shuwan Liu & Jing Hong. (2022) Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells. Transplantation and Cellular Therapy 28:11, pages 749.e1-749.e7.
Crossref
Hend Shater, Mary Fawzy, Alyaa Farid, Azza El-Amir, Salwa Fouad & Neveen Madbouly. (2022) B-cell activating factor and A proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus patients. The American Journal of the Medical Sciences 364:5, pages 646-654.
Crossref
Albert J. Czaja. (2022) Advancing Biologic Therapy for Refractory Autoimmune Hepatitis. Digestive Diseases and Sciences 67:11, pages 4979-5005.
Crossref
Miriam L. Fichtner, Kenneth B. Hoehn, Easton E. Ford, Marina Mane-Damas, Sangwook Oh, Patrick Waters, Aimee S. Payne, Melissa L. Smith, Corey T. Watson, Mario Losen, Pilar Martinez-Martinez, Richard J. Nowak, Steven H. Kleinstein & Kevin C. O’Connor. (2022) Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy. Acta Neuropathologica Communications 10:1.
Crossref
Chu-Jun Deng, Tak-Ho Lo, Ka-Ying Chan, Xiang Li, Meng-Yao Wu, Zou Xiang & Chi-Ming Wong. (2022) Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update. International Journal of Molecular Sciences 23:20, pages 12376.
Crossref
Yu Rebecca Miao, Kaushik Thakkar, Can Cenik, Dadi Jiang, Kazue Mizuno, Chenjun Jia, Caiyun Grace Li, Hongjuan Zhao, Anh Diep, Yu Xu, Xin Eric Zhang, Teddy Tat Chi Yang, Michaela Liedtke, Parveen Abidi, Wing-sze Leung, Albert C. Koong & Amato J. Giaccia. (2022) Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma. Journal of Experimental Medicine 219:9.
Crossref
Sophie Stephenson, Matthew A. Care, Gina M. Doody & Reuben M. Tooze. (2022) APRIL Drives a Coordinated but Diverse Response as a Foundation for Plasma Cell Longevity. The Journal of Immunology 209:5, pages 926-937.
Crossref
Nicolás Lundahl Ciano-Petersen, Sergio Muñiz-Castrillo, Cristina Birzu, Alberto Vogrig, Antonio Farina, Macarena Villagrán-García, Bastien Joubert, Dimitri Psimaras & Jérôme Honnorat. (2022) Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis. Brain Communications 4:4.
Crossref
Xunyao Wu, Yu Peng, Jieqiong Li, Panpan Zhang, Zheng Liu, Hui Lu, Linyi Peng, Jiaxin Zhou, Yunyun Fei, Xiaofeng Zeng, Yan Zhao & Wen Zhang. (2022) Single-Cell Sequencing of Immune Cell Heterogeneity in IgG4-Related Disease. Frontiers in Immunology 13.
Crossref
Dita Maixnerova, Delphine El Mehdi, Dana V. Rizk, Hong Zhang & Vladimir Tesar. (2022) New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies. Journal of Clinical Medicine 11:10, pages 2810.
Crossref
Yuan Min Wang, Karli Shaw, Geoff Yu Zhang, Edmund Y.M. Chung, Min Hu, Qi Cao, Yiping Wang, Guoping Zheng, Huiling Wu, Steven J. Chadban, Hugh J. McCarthy, David C.H. Harris, Fabienne Mackay, Shane T. Grey & Stephen I. Alexander. (2022) Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor. Journal of the American Society of Nephrology 33:5, pages 966-984.
Crossref
Hossam Hodeib, Doaa El Amrousy, Amira Youssef, Eman Elaskary & Mohamed H. Fouda. (2022) BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A. Haemophilia 28:3, pages 472-479.
Crossref
Yidan Zhang, Jie Tian, Fan Xiao, Leting Zheng, Xiaoxia Zhu, Ling Wu, Cheng Zhao, Shengjun Wang, Ke Rui, Hejian Zou & Liwei Lu. (2022) B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews 64, pages 57-70.
Crossref
Eric Eldering. (2022) A BAFFling <i>ménage à trois</i> in mantle cell lymphoma. Haematologica 107:12, pages 2774-2775.
Crossref
Gang Wang, Menglin Li, Jing Zheng, Jiabin Zhan, Huiyuan Zheng, Rui Li & Xin Wei. (2022) Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence. International Immunopharmacology 104, pages 108515.
Crossref
嘉欣 张. (2022) The New Progress of Treatment in IgA Nephropathy. Advances in Clinical Medicine 12:08, pages 7032-7041.
Crossref
Martin Aringer, Marta E. Alarcón-Riquelme, Megan Clowse, Guillermo J. Pons-Estel, Edward M. Vital & Maria Dall’Era. (2022) A glimpse into the future of systemic lupus erythematosus. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210867.
Crossref
Jiawei Wang, Jiyuan Yang & Jindřich Kopeček. (2022) Nanomedicines in B cell-targeting therapies. Acta Biomaterialia 137, pages 1-19.
Crossref
Nathalie Sturm & Bertrand Huard. 2022. Translational Autoimmunity. Translational Autoimmunity 179 191 .
Masaki Hirose, Toru Arai, Chikatoshi Sugimoto, Takayuki Takimoto, Reiko Sugawara, Shojiro Minomo, Sayoko Shintani, Naoko Takeuchi, Kanako Katayama, Yasushi Inoue, Tomoko Kagawa, Takahiko Kasai, Masanori Akira & Yoshikazu Inoue. (2021) B cell‐activating factors in autoimmune pulmonary alveolar proteinosis. Orphanet Journal of Rare Diseases 16:1.
Crossref
Preeti Gautam, Aman Sharma & Archana Bhatnagar. (2021) Global histone modification analysis reveals hypoacetylated H3 and H4 histones in B Cells from systemic lupus erythematosus patients. Immunology Letters 240, pages 41-45.
Crossref
Jianan Zhao, Shicheng Guo, Steven J. Schrodi & Dongyi He. (2021) Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications. Frontiers in Immunology 12.
Crossref
Qi Bian, Joshua C. Anderson, Xian Wen Zhang, Zhi Qiang Huang, Kerstin Ebefors, Jenny Nyström, Stacy Hall, Lea Novak, Bruce A. Julian, Christopher D. Willey & Jan Novak. (2021) Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation. Kidney Medicine 3:6, pages 1003-1013.e1.
Crossref
Bin Wang, Shiju Chen, Yan Li, Jingxiu Xuan, Yuan Liu & Guixiu Shi. (2021) Targeted Therapy for Primary Sjögren’s Syndrome: Where are We Now?. BioDrugs 35:6, pages 593-610.
Crossref
Tian-shu YuHao-yi WangYa-jing ZhaoYa-fei Yu, Yu Hou, Shuang LiuPan-pan HanXiao-fei NiXue-bin JiJun Peng, Xin-guang LiuMing Hou. (2021) Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Advances 5:20, pages 4087-4101.
Crossref
A. I. Malyshkina, N. Yu. Sotnikova, A. V. Kust & D. N. Voronin. (2021) REGULATION OF PERIPHERAL B-LYMPHOCYTE DIFFERENTIATION IN RECURRENT MISCARRIAGE. Medical Immunology (Russia) 23:4, pages 711-716.
Crossref
Alexandra Lushnikova, Johan Bohr, Anna Wickbom, Andreas Münch, Klas Sjöberg, Olof Hultgren, Anders Wirén & Elisabeth Hultgren Hörnquist. (2021) Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls. Frontiers in Medicine 8.
Crossref
Anna I. Malyshkina, Natalia Y. Sotnikova, Dmitriy N. Voronin & Alena V. Kust. (2021) Regulation of the functional activity of peripheral B lymphocytes in pregnant women with a history of recurrent miscarriage. Journal of obstetrics and women's diseases 70:4, pages 73-79.
Crossref
Albert J. Czaja. (2021) Review article: targeting the B cell activation system in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 54:7, pages 902-922.
Crossref
Pierre Ronco, Laurence Beck, Hanna Debiec, Fernando C. Fervenza, Fan Fan Hou, Vivekanand Jha, Sanjeev Sethi, Allison Tong, Marina Vivarelli & Jack Wetzels. (2021) Membranous nephropathy. Nature Reviews Disease Primers 7:1.
Crossref
Miao-miao Han, Xin-rong Yuan, Xiang Shi, Xing-Yu Zhu, Yue Su, De-Kai Xiong, Xing-Min Zhang, Huan Zhou & Ji-Nian Wang. (2021) The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Frontiers in Pharmacology 12.
Crossref
Desmond Y. H. Yap, Jojo Hai, Paul C. H. Lee, Xueying Zhou, Michael Lee, Yu Zhang, Meng Wang & Xiaoxiang Chen. (2021) Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers. Clinical and Translational Science 14:5, pages 1769-1779.
Crossref
Xin Huang & Gaosi Xu. (2021) An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective. Frontiers in Pharmacology 12.
Crossref
Zhaohao Huang, Binyao ChenXiuxing LiuHe LiLihui XieYuehan GaoRunping Duan, Zhaohuai Li, Jian Zhang, Yingfeng ZhengWenru Su. (2021) Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proceedings of the National Academy of Sciences 118:33.
Crossref
Laurie Baert, Romain Marignier, Hans P. Lassmann & Bertrand Huard. (2021) Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica. Frontiers in Neurology 12.
Crossref
Laurie Baert, Mashal Claude Ahmed, Benoit Manfroi & Bertrand Huard. (2021) The number 13 of the family: a proliferation inducing ligand. Current Opinion in Immunology 71, pages 132-137.
Crossref
Qin Shao. (2020) Biologic therapy in Sjögren’s syndrome. Clinical Rheumatology 40:6, pages 2143-2154.
Crossref
Silvia Piantoni, Francesca Regola, Stefania Masneri, Michele Merletti, Torsten Lowin, Paolo Airò, Angela Tincani, Franco Franceschini, Laura Andreoli & Georg Pongratz. (2021) Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. Frontiers in Pharmacology 12.
Crossref
Roberto MAGLIE, Emiliano ANTIGA & Aimee S. PAYNE. (2021) B-cell targeted therapies in pemphigus. Italian Journal of Dermatology and Venereology 156:2.
Crossref
Paulina Bryl-Górecka, Kreema James, Kristina Torngren, Inger Haraldsson, Li-Ming Gan, Sara Svedlund, Björn Olde, Thomas Laurell, Elmir Omerovic & David Erlinge. (2021) Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease. American Journal of Physiology-Heart and Circulatory Physiology 320:5, pages H2147-H2160.
Crossref
Yao Wang, Xi Jia, Ling Zhou, Jie Yin, Yunxiao Zhao, Lan Dai, Bin Zuo & Yang He. (2021) Increased let-7b-5p is associated with enhanced BAFF-R expression and B cell survival in immune thrombocytopenia. International Immunopharmacology 93, pages 107393.
Crossref
Xueting Yao, Yupeng Ren, Qian Zhao, Xia Chen, Ji Jiang, Dongyang Liu & Pei Hu. (2021) Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis. European Journal of Pharmaceutical Sciences 159, pages 105704.
Crossref
Senka Sendic, Ladan Mansouri, Sigrid Lundberg, Anna Nopp, Stefan H. Jacobson & Joachim Lundahl. (2021) B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy. PLOS ONE 16:3, pages e0248056.
Crossref
Zhi-Hui Xiong, Xiao-Song Cao, Hai-Lian Guan & Hui-Ling Zheng. (2020) Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature. World Journal of Clinical Cases 8:24, pages 6396-6407.
Crossref
Keiko Yoshimoto, Katsuya Suzuki, Eriko Takei, Yumi Ikeda & Tsutomu Takeuchi. (2020) Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren’s syndrome. Arthritis Research & Therapy 22:1.
Crossref
Mohamed Taha, Olfat Gamil Shaker, Enas Abdelsalam & Noha Taha. (2020) Serum a proliferation-inducing ligand and MicroRNA-223 are associated with rheumatoid arthritis: diagnostic and prognostic implications. Molecular Medicine 26:1.
Crossref
Torsten Lowin, Tareq M. Anssar, Marina Bäuml, Tim Classen, Matthias Schneider & Georg Pongratz. (2020) Positive and negative cooperativity of TNF and Interferon-γ in regulating synovial fibroblast function and B cell survival in fibroblast/B cell co-cultures. Scientific Reports 10:1.
Crossref
Bradley G. Phillips, Ye Wang, Suresh Ambati, Ping Ma & Richard B. Meagher. (2020) Airways therapy of obstructive sleep apnea dramatically improves aberrant levels of soluble cytokines involved in autoimmune disease. Clinical Immunology 221, pages 108601.
Crossref
Dita Maixnerova & Vladimir Tesar. (2020) Emerging Modes of Treatment of IgA Nephropathy. International Journal of Molecular Sciences 21:23, pages 9064.
Crossref
Mitra P. Maz & J. Michelle Kahlenberg. (2020) Cutaneous and systemic connections in lupus. Current Opinion in Rheumatology 32:6, pages 583-589.
Crossref
Monika Jasek, Agnieszka Bojarska-Junak, Maciej Sobczyński, Marta Wagner, Sylwia Chocholska, Jacek Roliński, Dariusz Wołowiec & Lidia Karabon. (2020) Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules. Cancers 12:10, pages 2873.
Crossref
Yubin Liu, Xiuxia Li, Yang Han, Zhifeng Qiu, Xiaojing Song, Bingxiang Li, Han Zhang, Hongye Wang, Kai Feng, Longding Liu, Jingjing Wang, Ming Sun & Taisheng Li. (2020) High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients. Frontiers in Medicine 7.
Crossref
Anna Wardowska, Michał Komorniczak, Aneta Skoniecka, Barbara Bułło-Piontecka, Katarzyna A. Lisowska, M.Alicja Dębska-Ślizień & Michał Pikuła. (2020) Alterations in peripheral blood B cells in systemic lupus erythematosus patients with renal insufficiency. International Immunopharmacology 83, pages 106451.
Crossref
Miriam L. Fichtner, Ruoyi Jiang, Aoibh Bourke, Richard J. Nowak & Kevin C. O’Connor. (2020) Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. Frontiers in Immunology 11.
Crossref
Mindy S. Lo. (2020) A framework for understanding Kawasaki disease pathogenesis. Clinical Immunology 214, pages 108385.
Crossref
Daniela Giordano, Runa Kuley, Kevin E. Draves, Kelsey Roe, Ursula Holder, Natalia V. Giltiay & Edward A. Clark. (2020) BAFF Produced by Neutrophils and Dendritic Cells Is Regulated Differently and Has Distinct Roles in Antibody Responses and Protective Immunity against West Nile Virus. The Journal of Immunology 204:6, pages 1508-1520.
Crossref
David N. Assis. (2020) Immunopathogenesis of Autoimmune Hepatitis. Clinical Liver Disease 15:3, pages 129-132.
Crossref
Salvatore Sutti & Emanuele Albano. (2019) Adaptive immunity: an emerging player in the progression of NAFLD. Nature Reviews Gastroenterology & Hepatology 17:2, pages 81-92.
Crossref
Daniela Willen, Wolfgang Uhl, Peter Wolna, Orestis Papasouliotis & Özkan Yalkinoglu. (2019) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects. European Journal of Drug Metabolism and Pharmacokinetics 45:1, pages 27-40.
Crossref
Wolfgang Schuh, Dirk Mielenz & Hans-Martin Jäck. 2020. 57 107 .
E L. Nasonov, T. V. Beketova, L. P. Ananyeva, V. I. Vasilyev, S. K. Solovyev & A. S. Avdeeva. (2019) PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES. Rheumatology Science and Practice 57, pages 1-40.
Crossref
Fatin N. Mohd Jaya, Sergio G. Garcia, Francesc E. Borràs, Godfrey C.F. Chan & Marcella Franquesa. (2019) Paradoxical role of Breg-inducing cytokines in autoimmune diseases. Journal of Translational Autoimmunity 2, pages 100011.
Crossref
Scott Taylor, Kyriaki Pieri, Paolo Nanni, Jure Tica, Jonathan Barratt & Athanasios Didangelos. (2019) Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys. Journal of Autoimmunity 105, pages 102309.
Crossref
Zhi-Chao Yuan, Wang-Dong Xu, Xiao-Yan Liu, Xing-You Liu, An-Fang Huang & Lin-Chong Su. (2019) Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases. Frontiers in Immunology 10.
Crossref
Natalie M. Bath, Xiang Ding, Bret M. Verhoven, Nancy A. Wilson, Lauren Coons, Adarsh Sukhwal, Weixiong Zhong & Robert R. Redfield III. (2019) Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model. PLOS ONE 14:10, pages e0223889.
Crossref
Charles-Antoine Dutertre, Etienne Becht, Sergio Erdal Irac, Ahad Khalilnezhad, Vipin Narang, Shabnam Khalilnezhad, Pei Y. Ng, Lucas L. van den Hoogen, Jing Yao Leong, Bernett Lee, Marion Chevrier, Xiao Meng Zhang, Pearly Jean Ai Yong, Geraldine Koh, Josephine Lum, Shanshan Wu Howland, Esther Mok, Jinmiao Chen, Anis Larbi, Henry Kun Kiaang Tan, Tony Kiat Hon Lim, Panagiota Karagianni, Athanasios G. Tzioufas, Benoit Malleret, Joshua Brody, Salvatore Albani, Joel van Roon, Timothy Radstake, Evan W. Newell & Florent Ginhoux. (2019) Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity 51:3, pages 573-589.e8.
Crossref
Li-Jun Liu, Ya-zi Yang, Su-Fang Shi, Yun-Fei Bao, Chao Yang, Sai-Nan Zhu, Gui-Li Sui, Yu-Qing Chen, Ji-Cheng Lv & Hong Zhang. (2019) Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial. American Journal of Kidney Diseases 74:1, pages 15-22.
Crossref
Andrew M. Wollacott, Luke N. Robinson, Boopathy Ramakrishnan, Hamid Tissire, Karthik Viswanathan, Zachary Shriver & Gregory J. Babcock. (2019) Structural prediction of antibody-APRIL complexes by computational docking constrained by antigen saturation mutagenesis library data. Journal of Molecular Recognition 32:7, pages e2778.
Crossref
Andreas Kronbichler, Biljana Brezina, Philipp Gauckler, Luis F. Quintana & David R.W. Jayne. (2019) Refractory lupus nephritis: When, why and how to treat. Autoimmunity Reviews 18:5, pages 510-518.
Crossref
Haresh Selvaskandan, Chee Kay Cheung, Masahiro Muto & Jonathan Barratt. (2019) New strategies and perspectives on managing IgA nephropathy. Clinical and Experimental Nephrology 23:5, pages 577-588.
Crossref
Laura C. Lane, Kathleen R. Allinson, Katy Campbell, Ishita Bhatnagar, Lorna Ingoe, Salman Razvi, Tim Cheetham, Heather J. Cordell, Simon H. Pearce & Anna L. Mitchell. (2019) Analysis of BAFF gene polymorphisms in UK Graves’ disease patients. Clinical Endocrinology 90:1, pages 170-174.
Crossref
Erin E. Hillhouse, Stéphanie Thiant, Moutuaata M. Moutuou, Félix Lombard-Vadnais, Rachel Parat, Jean-Sébastien Delisle, Imran Ahmad, Denis-Claude Roy, Martin Guimond, Jean Roy & Sylvie Lesage. (2019) Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity. Biology of Blood and Marrow Transplantation 25:1, pages 19-25.
Crossref
Yumi Tsuchida & Keishi Fujio. 2019. Mosaic of Autoimmunity. Mosaic of Autoimmunity 127 141 .
Ewa Kontny, Aleksandra Lewandowska-Poluch, Magdalena Chmielińska & Marzena Olesińska. (2018) Subgroups of Sjögren’s syndrome patients categorised by serological profiles: clinical and immunological characteristics. Rheumatology 56:6, pages 346-353.
Crossref
Laurie Baert, Benoit Manfroi, Olivier Casez, Nathalie Sturm & Bertrand Huard. (2018) The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting. Journal of Autoimmunity 95, pages 179-190.
Crossref
Christine Kowalczyk-Quintas, Dehlia Chevalley, Laure Willen, Camilla Jandus, Michele Vigolo & Pascal Schneider. (2018) Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab. Frontiers in Immunology 9.
Crossref
Konstantia Psianou, Ioannis Panagoulias, Anastasios D. Papanastasiou, Anne-Lise de Lastic, Maria Rodi, Panagiota I. Spantidea, Søren E. Degn, Panagiotis Georgiou & Athanasia Mouzaki. (2018) Clinical and immunological parameters of Sjögren's syndrome. Autoimmunity Reviews 17:10, pages 1053-1064.
Crossref
Edgar Meinl, Franziska S. Thaler & Stefan F. Lichtenthaler. (2018) Shedding of BAFF/APRIL Receptors Controls B Cells. Trends in Immunology 39:9, pages 673-676.
Crossref
Haiyan Xu, Xiaozhou He & Renfang Xu. (2018) B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome. Journal of Immunology Research 2018, pages 1-5.
Crossref
Edina Schweighoffer & Victor LJ Tybulewicz. (2018) Signalling for B cell survival. Current Opinion in Cell Biology 51, pages 8-14.
Crossref
Michele Vigolo, Melissa G. Chambers, Laure Willen, Dehlia Chevalley, Klaus Maskos, Alfred Lammens, Aubry Tardivel, Dolon Das, Christine Kowalczyk-Quintas, Sonia Schuepbach-Mallepell, Cristian R. Smulski, Mahya Eslami, Antonius Rolink, Edith Hummler, Eileen Samy, Yves Fomekong Nanfack, Fabienne Mackay, Maofu Liao, Henry Hess, Xuliang Jiang & Pascal Schneider. (2018) A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors. Nature Communications 9:1.
Crossref
Kenneth F Baker & John D Isaacs. (2018) Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?. Annals of the Rheumatic Diseases 77:2, pages 175-187.
Crossref
Eric Sanchez, Emily J. Smith, Moryel A. Yashar, Saurabh Patil, Mingjie Li, Autumn L. Porter, Edward J. Tanenbaum, Remy E. Schlossberg, Camilia M. Soof, Tara Hekmati, George Tang, Cathy S. Wang, Haiming Chen & James R. Berenson. (2017) The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma. Targeted Oncology 13:1, pages 39-47.
Crossref
Bert A. 't Hart, Jon D. Laman & Yolanda S. Kap. (2018) Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery. Clinical Pharmacology & Therapeutics 103:2, pages 262-270.
Crossref
Hirofumi Ochi. (2017) Genetic trade-off: Resistance to malaria or susceptibility to multiple sclerosis. Clinical and Experimental Neuroimmunology 8:4, pages 287-288.
Crossref
Jinrong Zeng, Haijing Wu, Ming Zhao & Qianjin Lu. (2017) Novel biomarkers for systemic lupus erythematosus. Biomarkers in Medicine 11:8, pages 677-686.
Crossref